Daniel Lynch, Director at bluebird bio, Inc. (BLUE), sold 3,300 shares at $87.10 ($291K) on 2017-03-24, disclosed to the SEC on 2017-03-28.
Open-market sale of $291k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.10 | 1,700 | $148K | 50.9% |
| 2 | $87.63 | 300 | $26K | 9.0% |
| 3 | $87.63 | 300 | $26K | 9.0% |
| 4 | $90.00 | 1,000 | $90K | 31.0% |
| Total | $88.07 avg | 3,300 | $291K | 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-16 | $1.0M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |